908 Devices (MASS) EPS (Basic) Growth (1y) (2021 - 2026)
908 Devices (MASS) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.85% |
| 10 | 908 Devices | 386.52 Mn | 284.99 Mn | 8.34 Mn | 14.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,741.92% |
| Mar 31, 2026 | -126.76% |
| Dec 31, 2025 | 94.34% |
| Sep 30, 2025 | 98.78% |
| Jun 30, 2025 | 92.40% |
| Mar 31, 2025 | 1,083.66% |
| Dec 31, 2024 | 56.42% |
| Sep 30, 2024 | 25.72% |
| Jun 30, 2024 | 49.68% |
| Mar 31, 2024 | 60.84% |
| Dec 31, 2023 | 25.88% |
| Sep 30, 2023 | -10.73% |
| Jun 30, 2023 | -12.58% |
| Mar 31, 2023 | -14.58% |
| Dec 31, 2022 | -17.08% |
| Sep 30, 2022 | -5.82% |
| Jun 30, 2022 | 16.55% |
| Mar 31, 2022 | -53.20% |
| Dec 31, 2021 | 85.78% |
| Sep 30, 2021 | 46.32% |